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ABSTRACT
Purpose: To analyze the triple antimicrobial therapy in positive Helicobacter spp. dogs and to investigate recurrence. Methods: A 
total of 20 dogs underwent endoscopy followed by gastric biopsy using the rapid urease test and histopathology stained with Giemsa. 
Ten animals were treated with triple therapy recommended for humans and divided into control and experimental group. The control 
group was kept in isolation while the experimental group was placed in contact with positive animals during 60 days. Results: The 
prevalence of infection in animals in this experiment was 100%, and more frequent in the fundus and the gastric body. Therapy for 
7 days using clarithromycin, amoxicillin and lansoprazole was effective in 100% of the animals. Recurrence of the infection in 80% 
of dogs in the experimental group, while the control group remained eradicated after 60 days. Conclusion: Crowded environments 
associated with close contact with dogs infected with helicobacter are a determinant for transmission of Helicobacter spp. between 
canines. 
Key works: Helicobacter infections. Endoscopy. Gastric Mucosa. Dogs.
RESUMO
Objetivo: Avaliar a eficácia da terapia tríplice em cães naturalmente infectados pelo Helicobacter spp. e investigar a recorrência da 
infecção pelo contato com animais infectados. Métodos: Foram utilizados 20 cães, submetidos à endoscopia digestiva alta seguida de 
biopsia gástrica usando teste rápido da urease e histopatologia corada pelo Giemsa. Dez animais foram tratados com terapia tríplice 
preconizada para humanos e divididos em grupo controle e experimental. O grupo controle foi mantido em isolamento enquanto 
que o grupo experimento foi colocado em contato com os animais positivos durante 60 dias. Resultados: A prevalência da infecção 
nos animais deste experimento foi de 100%, e mais frequente no fundo e corpo gástrico. A terapia durante 7 dias empregando 
claritromicina, amoxicilina e lansoprazol foi eficaz em 100% dos animais. Houve recorrência da infecção em 80% dos cães do grupo 
experimental, enquanto que o grupo controle manteve-se erradicado após 60 dias. Conclusão: Ambientes aglomerados associado 
a íntimo contato com cães infectados por helicobactérias é fator determinante para transmissão do Helicobacter spp. entre caninos. 
Descritores: Infecção por Helicobacter . Endoscopia. Mucosa Gástrica. Cães.
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 Introduction
The Helicobacter gender was defined by ribossomic 
RNA composition studies of sequential hybridation of the bacteria 
DNA. Belonging to the VI gram-negative bacteria superfamily, 
they are microaerophyle bacteria, curved and spiral, of smooth 
surface, measuring close to 0,1um to 0,5um wide by 3um length 
having round extremities followed by flagellated tufts1.
After stating the relation between the presence of the 
Helicobacter pylori bacteria and the gastritis genesis, gastric and 
duodenal ulcer in human by Marshall and Warren2, other species 
of spiral bacteria were identified and described in many animal 
species including dogs3.
More than half of the world population is infected 
by Helicobacter pylori. It happens in about 40% in 
developed countries, 70% in developing countries and in low 
socioeconomical communities with low hygiene it is higher4,5.
In Brazil, recent studies using the urease test, 
histopathology and sorology on street dogs show 80% to 100% 
Helicobacter spp. prevalence, found with higher frequency at the 
fundus and gastric body6,7.
   The gastric Helicobacter commonly found in dogs 
are Helicobacter bizzozeroni, Helicobacter felis, Helicobacter 
heilmannii and Helicobacter salomonis8. 
The Helicobacter spp. transmission mechanisms are 
not clear yet. The fecal-oral and oral-oral ways are the most 
probable4,9.
Epidemiologic studies suggest that poor hygiene 
conditions, including contaminated food and water can be 
determinant factors to the transmission among humans and 
animals10.
The current therapy scheme indicated to the 
Helicobacter pylori eradication in humans is the triple therapy, 
which includes an acid secretion inhibitor in combination with 
two antibiotics11,12.
Metronidazole, clarithromycin, amoxicillin, tetracycline 
and furazolidone are the most used antimicrobial drugs11. 
According to the II Brazilian Consense about Helicobacter 
pylori, the therapy associated with clarithromycin, amoxicillin 
and a proton bomb inhibitor, is an efficient therapy, being 
indicated as first option for bacteria eradication12.
The bacteria reccurrence seems to occur in a discreet 
parcel of patients13,14. Scientific informations related to 
reinfection are still restricted and show that the levels are higher 
in developing countries13.
The understanding of the transmission ways seem to be 
fundamental to establish strategies to an efficient treatment and 
specially to control helicobacteriosis in humans and animals.
The objective of this research is to analyze, the 
Helicobacter spp. prevalence in the distinct stomach regions in 
the canine specie, the efficacy of the clarithromycin, amoxicillin 
and lansoprazole association to eradicate the bacteria in dogs and 
determine if there is infection reccurrence by direct contact with 
infected dogs.
Methods
This research had previous permission of the UNICAMP 
Ethics Committee of Animal Use, Biology Institute (protocol nº 
1801-1).
We included in the study 20 street dogs, adults, within 
close to 20kg, naturally infected with Helicobacter spp. confirmed 
diagnosis by the fast urease test and histology. The animals were 
maintained at the Veterinary Medicine Hospital Kennel from the 
Itajuba University Center – UNIVERSITAS, vermifugated and 
vaccined according to veterinary medical protocol.
To perform the high digestive endoscopy, all animals 
received associated 0.04 mg/kg atropine sulfate, 0.004 mg/kg 
fentanil citrate, 1 mg/kg acepromazine acetate by intramuscular 
injection as preanesthesic medication. The propofol was used at a 
3 mg/kg intravenous dosage as a general anesthesia inducer. The 
animals were left in spontaneous mechanical ventilation with 
oxygen at 100 vol%, electrocardiographic monitoring and wrist 
oximetry. Additional propofol doses were used when necessary.
Pentax Gastrofibroscope FG-29P was used with 250W 
halogen light source and permanent biopsy forceps.
Were collected two samples from the fundus, two 
from the body and two from the gastric antrum. One sample of 
each stomach region was immediately immersed in a standard 
solution for fast urease test. This study considered positive the 
sample which presented color change until 12 hours (Figure 
1). The second sample was immersed in a 10% formol solution 
for following histopathologic exam stained with Giemsa and 
modified Giemsa and bacteria identification increased 400x and 
1000x.
For each procedure the endoscope equipment was 
immersed in a 2% glutaraldehyde solution for a minimum time 
of 30 minutes after mechanical cleaning with enzymatic solution. 
The forceps biopsy was treated by autoclave cycles at 134ºC.
FIGURE 1 – Urease test showing positive and negative sample. 
The animals were divided into two 10 positive animal 
groups: Group I and Group II (Figure 2).
The group II animals were isolated in individual 
kennels and received therapy at 25 mg/kg clarithromycin, 50 mg/
kg amoxicillin and 1mg/kg lansoprazole (Helicopac® - EMS) 
every 12 hours during 7 days (Figure 2).
One day after the end of the therapy, the animals were 
submitted to a new upper digestive endoscopy examination to 
verify the bacteria eradication. Then, the animals were subdivided 
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into two subgroups (experimental and control) composed of five 
treated animals each (Figure 2).
The experimental group was placed again in contact 
with group I and the control group was maintained in individual 
isolation kennels, both during 60 days, when a third upper 
digestive endoscopy examination  was performed followed by 
Helicobacter spp. search (Figure 2).
FIGURE 2 – Division of the groups.
Weekly assessment was performed, during all research 
period. The exception occurred during the seven days medication 
therapy, when they received daily clinical assessment, within the 
intention to check possible adverse effects.
The Helicobacter spp. prevalence, its distribution 
along the gastric mucosa and the triple therapy accuracy were 
determined by the percentage descriptive analysis. To analyze 
the reinfection occurrence was performed the Fisher exact test. 
The Kappa coefficient was utilized at the concordance of the 
urease test and histopathology. 
  
Results
In the analyzed samples were seen spiral bacteria in the 
mucus, over the tissue surface, at the crypt bottom and inside the 
gastric glands (Figure 3).
The bacteria morphology found was similar in all dogs 
(Figure 4A). Both experimental group and control group, were 
seen long spiral bacterias similar to the species Helicobacter 
heilmannii e Helicobacter bizzozeroni (Figure 4B).
FIGURE 3 – A) Spiral bacterias in the mucus (white arrows), over the 
tissue surface and at the crypt (black arrows) (Giemsa 400x). B) Spiral 
bacterias in inside the gastric glands (black arrows) (Giemsa 400x).
According to the urease fast test, the fundus region 
and the gastric body showed 100% positivity, whereas the 
infection at the antrum was 60%. The positivity frequency for 
histopathologic Helicobacter spp. was 100% at the fundus, 90% 
at the body and only 50% at the antrum (Figure 5).
After group division, the isolated experimental group 
analysis resulted in 100% frequency at the fundus and body, 
and 80% at the gastric antrum according to the urease fast test 
(Figure 6). The histopathology was seen 100% prevalence at the 
fundus and 40% at the antrum (Figure 7).
FIGURE 4 – A) First endoscopy: Spiral bacterias at the gastric crypt 
(modified Giemsa 400x). B) Bacterias with morphological evidence of 
long spiral (modified Giemsa 1000x).
FIGURE 5 – Frequence of Helicobacter sp in the distinct stomach 
regions at the first endoscopy.
FIGURE 6 – Frequence Helicobacter sp in the distinct stomach regions 
in the experimental group according to the urease fast test.
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FIGURE 7 – Frequence of Helicobacter sp in the distinct stomach 
regions in the experimental group according histopathology.
The control group presented 100% positivity at 
the fundus and 60% at the gastric antrum (Figure 8). By the 
histopathology 100% at the fundus, 80% at the body and 60% at 
the antrum (Figure 9) were positives.
The triple therapy used was efficient in 100% of the 
animals after 7 days. The results were negatives at the urease 
fast tests and histopathologies in both experimental and control 
groups (Figures 8 and 9). Were not seen Helicobacter spp. at the 
tissues, at the gastric glands and at the mucus of the biopsied 
regions (Figure 10).
FIGURE 8 – Frequence of Helicobacter sp in the distinct stomach 
regions in the control group according to urease fast test.
FIGURE 9 – Frequence of Helicobacter sp in the distinct stomach 
regions in the control group according to the histopathology.
FIGURE 10 – A) Sample of the gastric fundus one day after the end of 
the triple therapy in control group (modified Giemsa 400x). B) Sample 
of the gastric fundus one day after the end of the triple therapy in 
experimental group (Giemsa 400x).
Third digestive endoscopy followed of biopsy 60 days 
after triple therapy showed that the control group continued 
eradicated (Figures 8 and 9). The Helicobacter spp. were absent 
in all samples (Figure 12). At the experimental group, 80% of the 
animals showed again Helicobacter spp. presence (p<0.05). The 
dogs that had Helicobacter spp. reinfection the fundus and the 
body showed positive in 100% of the cases and the antrum in only 
50%, according to the urease test (Figure 6). The histopathology 
identified the bacteria at the crypt bottom (Figure 11A), inside 
the glands (Figure 11B) and the mucus. The prevalence was 
100% at the fundus and body, and 80% at the antrum (Figure 7).
FIGURE 11 – A) Sample of the gastric fundus showing spiral bacterias 
at the third endoscopy in the experimental group (Giemsa 400x). B) 
Sample of the gastric fundus showing spiral bacterias inside the glands 
at the third endoscopy in the experimental group (Giemsa 400x).
Signs of gastrointestinal problems were not observed 
during the observation period. The possible adverse effects which 
followed the triple therapy used were not clinically detected.
FIGURE 12 – Sample of the gastric fundus without Helicobacter sp 
in the control group 60 days after the end of the triple therapy (Giemsa 
400x).
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Discussion
Helicobacter spp. are frequently found in dogs6-8,15, 
not only in healthy animals15, but also in dogs with gastropathy 
simptoms7.
The Helicobacter heilmannii, Helicobacter bizzozeroni, 
species are morphologically similar bacteria, show spiral evident 
format and smaller than Helicobacter pylory16,17. Helicobacter 
felis has periplasmatic fibrillations as a particularity18,19 and the 
Helicobacter salomonis are  larger microorganisms with discreet 
wavy morphology20. 
The Helicobacter spp. were seen in the mucus, over the 
tissue surface, at the crypt bottom and inside the gastric glands, 
adding that in this research the bacteria density was higher in 
areas with more mucus6,7.
The bacteria prevalence in street dogs and in dogs which 
live in crowded areas like, city kennels in Brazil is between 90% 
to 100%6,7,15,21. In a retrospective study performed in Colombia 
shows that the Helicobacter spp. prevalence in pet dogs is 50% 
less22. 
The results found in animals in this study were according 
to the veterinary literature agreeing to the high prevalence and 
it is supported by epidemiologic studies with human patients, 
infected with Helicobacter pylori, which live in collectivity, 
mainly in groups within a low socioeconomic level and within 
low hygiene, where it is observed high infection and reinfection 
average4.
Helicobacter pylori is more frequent at the gastric 
antrum region in humans1, however in dogs the fundus and body 
are presented with high bacteria density and higher probability to 
find Helicobacter spp.6,7,15,21. 
The urease fast test can present false negative and false 
positive results, being the histopathology the most sensible and 
indispensable technique in detecting gastric helicobacter in dogs. 
Stained histopathology by Giemsa and modified Giemsa allowed 
us easy seeing and microorganism identification at the positive 
urease test. The urease fast test negative result and the tests 
which the color change time occurred above 2 hours were related 
to histopathologic exams with helicobacter absence or low 
colonization density7,21-24. This work showed good concordance 
between the urease test and histopathology according Kappa 
coefficient.
The fact that the used therapy in this experiment was 
not followed by adverse effects, was observed using amoxicillin, 
metronidazole and colloidal bismuth subcitrate25,26.
The omeprazole, pantoprazole and lanzoprazole also 
can act, in vitro, as antimicrobial by inhibiting the bacteria 
urease21. And the lansoprazole seems to have pharmacological 
power and action time similar to omeprazole, and also present 
minimal side effects in North America dogs25,26.
The therapeutic failure as the cause o major reinfection 
rate and peptic disease reccurrence or recrudescence was 
described13,14, demonstrating that the triple therapy based in 
clarithromycin, amoxicillin and lansoprazole reduced in an 
efficient way the human reinfection cases13. 
Study with amoxicillin, metronidazole and bismuth 
subcitrate in dogs with gastropathy clinical signs, positive for 
Helicobacter spp, scored clinic status improvement in 80% of 
the animals. On this study 57% of the treated dogs showed again 
the Helicobacter spp. presence in the gastric mucosa after three 
years25.
According to this research, even with an efficient triple 
therapy, eradicated individuals can have a higher recurrence 
probability if maintained intimate contact with positive 
individuals, associated to low hygiene conditions, specially in 
crowded situations4.
The fecal-oral transmission was suggested at first for 
the Helicobacter pylori isolation in children diarrhea droppings4 
meanwhile the microorganism detection in the saliva and dental 
plaque in infected patients strengthened the oral-oral transmission 
hypothesis27.
Different helicobacter from Helicobacter pylori were 
also identified at healthy domestic animal oral cavity21,28,29. 
The Helicobacter pylori transmission among people was 
related after observing equal microorganism reinfection among 
married patients30.
Literature reviews described in Brazil and abroad state 
that the natural infection by different bacteria from Helicobacter 
pylori in human could be a sign of interspecies transmission. These 
studies suggest, with a lot care, a probable power zoonotic3,21,28,29.
This way the canine specie is, in our point of view, a 
good model to be used on experimental research, focusing on 
clarify and detail the real transmission mechanism and the bacteria 
control of this gender, in both animals and human.
Conclusions
The Helicobacter spp. is found in higher rate at the 
fundus and gastric body of the dogs. The triple therapy based 
in clarithromycin, amoxicilin and lansoprazole is an efficient 
treatment in eradicating Helicobacter spp. in dogs.
The recurrence by Helicobacter spp. occurs in eradicated 
dogs maintained in contact of 60 days with naturally infected 
dogs. Crowded situations and the intimate contact with infected 
dogs determine transmission of Helicobacter spp. in dogs.
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